SCHEMBL18624697

SCHEMBL18624697

CCSc1ccccc1C(=O)Nc1cc(C)ncc1O

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.56
ALOX15 P16050 3/20 0.56
HSD17B10 Q99714 3/20 0.54
ALDH1A1 P00352 6/20 0.50
HPGD P15428 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
PKM P14618 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
MAPT P10636 4/20 0.48
LMNA P02545 3/20 0.48
RXFP1 Q9HBX9 1/20 0.46
KCNMA1 Q12791 3/20 0.45
TSHR P16473 2/20 0.44
MEN1 O00255 1/20 0.44
USP2 O75604 1/20 0.44
TP53 P04637 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17008991 0.84 RXFP1 (0.52) MAPK1ALOX15HSD17B10ALDH1A1HPGD
SCHEMBL9952117 0.77 MAPK1 (0.54) MAPK1ALOX15HSD17B10ALDH1A1HPGD
SCHEMBL9952069 0.75 HSD17B10 (0.50) MAPK1ALOX15HSD17B10ALDH1A1HPGD
SCHEMBL17286442 0.74 MAPK1 (0.62) MAPK1ALOX15HSD17B10ALDH1A1HPGD
SCHEMBL16666910 0.74 RXFP1 (0.51) MAPK1ALOX15HSD17B10ALDH1A1HPGD
SCHEMBL15427212 0.74 HSD17B10 (0.51) MAPK1ALOX15HSD17B10ALDH1A1HPGD
SCHEMBL9952680 0.72 RXFP1 (0.49) MAPK1ALOX15HSD17B10ALDH1A1HPGD
SCHEMBL9952288 0.71 RXFP1 (0.48) MAPK1ALOX15HSD17B10ALDH1A1HPGD
SCHEMBL6942406 0.70 HPGD (0.57) MAPK1ALOX15HSD17B10ALDH1A1HPGD
SCHEMBL10839920 0.70 HPGD (0.61) MAPK1ALOX15HSD17B10ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170073342-A1 2-(HET)ARYL-SUBSTITUTED FUSED BICYCLIC HETEROCYCLE DERIVATIVES AS PESTICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170073342-A1 2-(HET)ARYL-SUBSTITUTED FUSED BICYCLIC HETEROCYCLE DERIVATIVES AS PESTICIDES CYP1B1, CYP4B1, CYP8B1 MAPK1 2792/4885ALOX15 185/4885HSD17B10 149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.